
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched an innovative initiative known as the “AI Airlock” scheme. This groundbreaking project aims to revolutionize the regulation of artificial intelligence (AI)-driven medical devices, streamlining their introduction into the UK’s National Health Service (NHS). The initiative’s primary goal is to ensure these advanced technologies are safe and effective for patient use,










